Disability in pediatric inflammatory bowel diseases: A systematic review and a single center experience
- Journal
- Journal of pediatric gastroenterology and nutrition (Q1)
- Published
- 22 September 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Reut Rappaport, Ouriel Hannaux, Gili Focht, Liron Marcovitch, Elana Gotkine, Ohad Atia, et al.
- PMID
- 42768931
- DOI
- 10.1002/jpn3.70596
Why clinicians should know about it
- Picked for Epidemiology (paper of the day, 24 September 2026): Systematic review of disability in pediatric IBD
Abstract
OBJECTIVES: Toward development of a pediatric IBD disability index (PIDI), we aimed to review the literature on disability in pediatric inflammatory bowel disease (PIBD) and to estimate disability rates in a pediatric inception cohort. METHODS: A systematic review identified studies reporting disability in PIBD and in adult randomized controlled trials (RCTs) with disability as the primary outcome. In parallel, seven disability-related IMPACT-III items were retrieved at 4 and 12 months after diagnosis from a prospectively followed inception cohort of PIBD. Items were scored 0-100 (≤75 mild, ≤50 moderate, and ≤25 severe disability), supported by a validation sub-study. RESULTS: Thirteen pediatric studies were included of which 10 used the functional disability inventory, a generic disability tool not developed for PIBD. Any disability was found in 55% and 100% in the two studies that reported rates. Three adult RCTs used generic patient-reported measures of participation in daily activities and showed modest, inconsistent improvement in disability with heterogenous interventions. The inception cohort included 80 children, of whom 38% had any disability at 4 months and 10% had moderate-severe disability. These rates declined to 18% and 0% at 12 months, respectively. Dietary restrictions, sports participation, travel, and school functioning were the most affected domains. At 4-months, any degree of disability was higher in those with active disease (61%) versus inactive disease (17%, p < 0.001). CONCLUSIONS: Disability literature in PIBD is scarce and lacks a pediatric-specific instrument. Functional limitations were frequent and persisted in some children despite reaching clinical remission. These findings underscore the need for standardized disability assessment in PIBD.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.